"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 11 | 11 |
| 2002 | 0 | 12 | 12 |
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 7 | 7 |
| 2006 | 0 | 9 | 9 |
| 2007 | 0 | 9 | 9 |
| 2008 | 0 | 18 | 18 |
| 2009 | 0 | 16 | 16 |
| 2010 | 0 | 20 | 20 |
| 2011 | 0 | 33 | 33 |
| 2012 | 0 | 37 | 37 |
| 2013 | 1 | 38 | 39 |
| 2014 | 1 | 39 | 40 |
| 2015 | 0 | 34 | 34 |
| 2016 | 0 | 31 | 31 |
| 2017 | 2 | 43 | 45 |
| 2018 | 0 | 47 | 47 |
| 2019 | 0 | 38 | 38 |
| 2020 | 0 | 31 | 31 |
| 2021 | 0 | 29 | 29 |
| 2022 | 0 | 21 | 21 |
| 2023 | 0 | 13 | 13 |
| 2024 | 0 | 20 | 20 |
| 2025 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes. Emerg Infect Dis. 2025 Mar; 31(3):467-476.
-
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. Lancet HIV. 2025 Mar; 12(3):e201-e213.
-
Extension Study With rVIII-SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A. Haemophilia. 2025 Mar; 31(2):214-223.
-
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis. Lancet Child Adolesc Health. 2025 Feb; 9(2):100-111.
-
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg. J Int AIDS Soc. 2025 Feb; 28(2):e26414.
-
Photobiomodulation therapy as an additional method for the treatment of temporomandibular disorder patients- a narrative review. Lasers Med Sci. 2025 Jan 31; 40(1):56.
-
Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial. Lancet Diabetes Endocrinol. 2025 Mar; 13(3):178-187.
-
Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection. AIDS Res Ther. 2024 Dec 30; 21(1):101.
-
A randomized trial for combination nicotine replacement therapy for smoking cessation among people with HIV in a low-resourced setting. AIDS. 2025 Apr 01; 39(5):526-534.
-
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors. Haemophilia. 2025 Jan; 31(1):78-86.